A novel 2,3-diphenyl-4H-pyrido[1,2-a]pyrimidin-4-one derivative inhibits endothelial cell dysfunction and smooth muscle cell proliferation/activation
Serena Del Turco(Istituto di Fisiologia Clinica), Giuseppina Basta(Istituto di Fisiologia Clinica), Teresa Navarra(Istituto di Fisiologia Clinica), Stefania Sartini(University of Pisa), Federico Da Settimo(University of Pisa), Concettina La Motta(University of Pisa), Chiara Saponaro(University of Pisa), Bianca Dario(University of Pisa), Cassandra Sentieri(Istituto di Fisiologia Clinica)
Cited by 23
Related Papers
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
|Nutrients|2015|530
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study
|Scientific Reports|2017|174
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
|Nature Medicine|2024|153
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
|Current Diabetes Reports|2015|145
Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions
|Cell Metabolism|2022|124